Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos Biliouris

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Systems Biology|January 21, 2011
Stochastic simulations of the tetracycline operonKonstantinos Biliouris, Prodromos Daoutidis, Yiannis N Kaznessis
ACS Chemical Biology|August 9, 2011
proTeOn and proTeOff, new protein devices that inducibly activate bacterial gene expressionKatherine Volzing, Konstantinos Biliouris, Yiannis N Kaznessis
Molecular Microbiology|July 1, 2014
Bacterial sugar utilization gives rise to distinct single-cell behavioursTaliman Afroz, Konstantinos Biliouris, Yiannis Kaznessis, et al.
BMC Systems Biology|June 8, 2012
Stochastic simulations of a synthetic bacteria-yeast ecosystemKonstantinos Biliouris, David Babson, Claudia Schmidt-Dannert, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 3, 2016
Systems pharmacology to predict drug safety in drug developmentMirjam N Trame, Konstantinos Biliouris, Lawrence J Lesko, et al.
ACS Synthetic Biology|April 17, 2014
Trade-offs in engineering sugar utilization pathways for titratable controlTaliman Afroz, Konstantinos Biliouris, Kelsey E Boykin, et al.
Frontiers in Pharmacology|August 9, 2020
Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis TherapySonja Hartmann, Konstantinos Biliouris, Lawrence J Lesko, et al.
Nature Immunology|October 6, 2015
Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8Heping Xu, Virendra K Chaudhri, Zhiguo Wu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2018
A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humansKonstantinos Biliouris, Ivan Nestorov, Himanshu Naik, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 27, 2020
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosusSonja Hartmann, Konstantinos Biliouris, Himanshu Naik, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Systems Biology|January 21, 2011
Stochastic simulations of the tetracycline operonKonstantinos Biliouris, Prodromos Daoutidis, Yiannis N Kaznessis
ACS Chemical Biology|August 9, 2011
proTeOn and proTeOff, new protein devices that inducibly activate bacterial gene expressionKatherine Volzing, Konstantinos Biliouris, Yiannis N Kaznessis
Molecular Microbiology|July 1, 2014
Bacterial sugar utilization gives rise to distinct single-cell behavioursTaliman Afroz, Konstantinos Biliouris, Yiannis Kaznessis, et al.
BMC Systems Biology|June 8, 2012
Stochastic simulations of a synthetic bacteria-yeast ecosystemKonstantinos Biliouris, David Babson, Claudia Schmidt-Dannert, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 3, 2016
Systems pharmacology to predict drug safety in drug developmentMirjam N Trame, Konstantinos Biliouris, Lawrence J Lesko, et al.
ACS Synthetic Biology|April 17, 2014
Trade-offs in engineering sugar utilization pathways for titratable controlTaliman Afroz, Konstantinos Biliouris, Kelsey E Boykin, et al.
Frontiers in Pharmacology|August 9, 2020
Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis TherapySonja Hartmann, Konstantinos Biliouris, Lawrence J Lesko, et al.
Nature Immunology|October 6, 2015
Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8Heping Xu, Virendra K Chaudhri, Zhiguo Wu, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2018
A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humansKonstantinos Biliouris, Ivan Nestorov, Himanshu Naik, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 27, 2020
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosusSonja Hartmann, Konstantinos Biliouris, Himanshu Naik, et al.
Pageof 2